Editas Medicine
EDIT
$5.34
Share price
2.59%
Change (1 day)
-35.60%
Change (1 year)
Editas Medicine (EDIT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.15 B
According to Editas Medicine 's latest financial reports the company's total liabilities are $0.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Editas Medicine - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | -2.33% |
| 2022-12-31 | $0.15 B | 24.06% |
| 2021-12-31 | $0.12 B | -30.82% |
| 2020-12-31 | $0.17 B | -27.36% |
| 2019-12-31 | $0.24 B | 33.78% |
| 2018-12-31 | $0.18 B | 11.53% |
| 2017-12-31 | $0.16 B | 74.66% |
| 2016-12-31 | $94.57 M | -59.32% |
| 2015-12-31 | $0.23 B | 745.99% |
| 2014-12-31 | $27.48 M | 547.5% |
| 2013-12-31 | $4.24 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.69 M | -98.20% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -18.69% | 🇬🇧 UK |
 Novavax NVAX | $2.51 B | 1,575.65% | 🇺🇸 USA |
 Novocure
NVCR | $0.78 B | 422.23% | Jersey |